VERORABVAX Trademark

Trademark Overview


On Tuesday, November 14, 2023, a trademark application was filed for VERORABVAX with the United States Patent and Trademark Office. The USPTO has given the VERORABVAX trademark a serial number of 98268892. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2024. This trademark is owned by Sanofi Pasteur. The VERORABVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
verorabvax

General Information


Serial Number98268892
Word MarkVERORABVAX
Filing DateTuesday, November 14, 2023
Status700 - REGISTERED
Status DateTuesday, August 20, 2024
Registration Number7482225
Registration DateTuesday, August 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Pasteur
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events


Event DateEvent Description
Friday, November 17, 2023NEW APPLICATION ENTERED
Tuesday, November 28, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, November 28, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, December 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, May 2, 2024ASSIGNED TO EXAMINER
Wednesday, May 8, 2024ASSIGNED TO LIE
Wednesday, May 8, 2024ASSIGNED TO LIE
Wednesday, May 8, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, June 17, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, July 15, 2024ASSIGNED TO PETITION STAFF
Tuesday, August 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords


verorabvax human vaccines